Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and alfentanil dose-finding for painless oocyte retrieval
ChiCTR2400083913Phase 4Not yet recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and alfentanil in None (8 arms), sponsored by Shanxi Bethune Hospital. Primary endpoint: Plasma concentrations of alfentanil and propofol in each patient at the time of sedation and analgesia. Planned start May 2024; status: not yet recruiting.
02
Drugs
propofolalfentanil
Beyond the preview
Go deeper on ChiCTR2400083913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083913.